Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: Transarterial chemoembolization (TACE) is the recommended treatment for hepatocellular carcinoma (HCC) patients at Barcelona Clinic Liver Cancer (BCLC) B-stage, whereas sorafenib is an orally administered small molecule target drug for BCLC C-stage. This updated systemic review and meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Zhao, Wenzhuo, Wang, Mengmeng, Hu, Jie, Wang, Enxin, Zhao, Yan, Liu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124009/
https://www.ncbi.nlm.nih.gov/pubmed/30180810
http://dx.doi.org/10.1186/s12876-018-0849-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124009/
https://www.ncbi.nlm.nih.gov/pubmed/30180810
http://dx.doi.org/10.1186/s12876-018-0849-0

Ejemplares similares